Increased p53 protein expression as a potential predictor of early relapse after hematopoietic stem cell transplantation in children with acute myelogenous leukemia

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pediatric Transplantation

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/petr.12585PMID 26432780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

  2014cited by this paper
• A critical review of which children with acute myeloid leukaemia need stem cell procedures

  2014influential reference
• Elevated p53 Protein Expression; A Predictor of Relapse in Rare Chronic Myeloid Malignancies in Children?

  2014cited by this paper
• Functional Analysis of the ATM-p53-p21 Pathway in the LRF CLL4 Trial: Blockade at the Level of p21 Is Associated with Short Response Duration

  2012cited by this paper
• The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.

  2012cited by this paper
• Cellular senescence and tumor suppressor gene p16

  2012cited by this paper
• Pediatric acute myeloid leukemia

  2012cited by this paper
• Pediatric Acute Myeloid Leukemia

  2011cited by this paper
• EXPRESSION OF PTEN AND SHP1, INVESTIGATED FROM TISSUE MICROARRAYS IN PEDIATRIC ACUTE LYMPHOBLASTIC, LEUKEMIA

  2009cited by this paper
• Outcome of allogeneic hematopoietic stem cell transplantation for children with acute myelogenous leukemia in second complete remission: Single center experience

  2009cited by this paper
• Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group.

  2008cited by this paper
• Pediatric acute myeloid leukemia: international progress and future directions

  2005cited by this paper
• p16(MTS-1/CDKN2/INK4a) in cancer progression.

  2001cited by this paper
• Cellular expression of MDM2 and p53 in childhood leukemias with poor prognosis.

  2000cited by this paper
• Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

  1998cited by this paper

• Immunohistochemistry screening for TP53 mutation in myeloid neoplasms in AZF-fixed bone marrow biopsies.

  2024cites this paper
• WT1 and TP53 as valuable diagnostic biomarkers for relapse after hematopoietic stem cell transplantation in acute myeloid leukemia

  2024cites this paper
• From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy

  2024cites this paper
• Strong expression of p53 protein in bone marrow samples after hematopoietic stem cell transplantation indicates risk of relapse in pediatric acute lymphoblastic leukemia patients

  2019cites this paper
• The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications

  2017cites this paper
• Induction of K562 Cell Apoptosis by As4S4 via Down-Regulating miR181

  2017cites this paper
• MicroRNAs and regulated interaction networks reveal differences between adult and pediatric acute myeloid leukemia.

  2017cites this paper
• Enforced miR-144-3p Expression as a Non-Invasive Biomarker for the Acute Myeloid Leukemia Patients Mainly by Targeting NRF2.

  2017cites this paper